224 related articles for article (PubMed ID: 12231378)
1. Comparison of the effects of zaleplon, zolpidem, and triazolam at various GABA(A) receptor subtypes.
Sanna E; Busonero F; Talani G; Carta M; Massa F; Peis M; Maciocco E; Biggio G
Eur J Pharmacol; 2002 Sep; 451(2):103-10. PubMed ID: 12231378
[TBL] [Abstract][Full Text] [Related]
2. Modulation of [35S]TBPS binding by ligands with preferential affinity for benzodiazepine BZ1 sites in the cerebral cortex of newborn and adult rats.
Giorgi O; Lecca D; Cancedda E; Serra GP; Corda MG
Eur J Pharmacol; 1995 Jun; 290(1):37-47. PubMed ID: 7664823
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the interaction of indiplon, a novel pyrazolopyrimidine sedative-hypnotic, with the GABAA receptor.
Sullivan SK; Petroski RE; Verge G; Gross RS; Foster AC; Grigoriadis DE
J Pharmacol Exp Ther; 2004 Nov; 311(2):537-46. PubMed ID: 15256540
[TBL] [Abstract][Full Text] [Related]
4. Probing the molecular basis for affinity/potency- and efficacy-based subtype-selectivity exhibited by benzodiazepine-site modulators at GABA
Söderhielm PC; Balle T; Bak-Nyhus S; Zhang M; Hansen KM; Ahring PK; Jensen AA
Biochem Pharmacol; 2018 Dec; 158():339-358. PubMed ID: 30121248
[TBL] [Abstract][Full Text] [Related]
5. Effect of zaleplon on learning and memory in rats.
Noguchi H; Kitazumi K; Mori M; Shiba T
Naunyn Schmiedebergs Arch Pharmacol; 2002 Aug; 366(2):183-8. PubMed ID: 12122506
[TBL] [Abstract][Full Text] [Related]
6. Prevalence between different alpha subunits performing the benzodiazepine binding sites in native heterologous GABA(A) receptors containing the alpha2 subunit.
del Río JC; Araujo F; Ramos B; Ruano D; Vitorica J
J Neurochem; 2001 Oct; 79(1):183-91. PubMed ID: 11595770
[TBL] [Abstract][Full Text] [Related]
7. The activity of zolpidem and other hypnotics within the gamma-aminobutyric acid (GABAA) receptor supramolecular complex, as determined by 35S-t-butylbicyclophosphorothionate (35S-TBPS) binding to rat cerebral cortex membranes.
Lloyd GK; Danielou G; Thuret F
J Pharmacol Exp Ther; 1990 Nov; 255(2):690-6. PubMed ID: 2173755
[TBL] [Abstract][Full Text] [Related]
8. Limited anxiolytic-like effects of non-benzodiazepine hypnotics in rodents.
Griebel G; Perrault G; Sanger DJ
J Psychopharmacol; 1998; 12(4):356-65. PubMed ID: 10065909
[TBL] [Abstract][Full Text] [Related]
9. Identification of amino acid residues responsible for the alpha5 subunit binding selectivity of L-655,708, a benzodiazepine binding site ligand at the GABA(A) receptor.
Casula MA; Bromidge FA; Pillai GV; Wingrove PB; Martin K; Maubach K; Seabrook GR; Whiting PJ; Hadingham KL
J Neurochem; 2001 Apr; 77(2):445-51. PubMed ID: 11299307
[TBL] [Abstract][Full Text] [Related]
10. Zaleplon and triazolam: drug discrimination, plasma levels, and self-administration in baboons.
Ator NA
Drug Alcohol Depend; 2000 Dec; 61(1):55-68. PubMed ID: 11064184
[TBL] [Abstract][Full Text] [Related]
11. The hypnotics triazolam and zolpidem have identical metabolic effects throughout the brain: implications for benzodiazepine receptor subtypes.
Piercey MF; Hoffmann WE; Cooper M
Brain Res; 1991 Jul; 554(1-2):244-52. PubMed ID: 1657289
[TBL] [Abstract][Full Text] [Related]
12. Zaleplon and triazolam in humans: acute behavioral effects and abuse potential.
Rush CR; Frey JM; Griffiths RR
Psychopharmacology (Berl); 1999 Jul; 145(1):39-51. PubMed ID: 10445371
[TBL] [Abstract][Full Text] [Related]
13. Transduction of the discriminative stimulus effects of zolpidem by GABA(A)/alpha1 receptors.
Rowlett JK; Lelas S; Spealman RD
Eur J Pharmacol; 2000 Oct; 406(1):R9-R10. PubMed ID: 11011051
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the effects of zaleplon, zolpidem, and triazolam on memory, learning, and psychomotor performance.
Troy SM; Lucki I; Unruh MA; Cevallos WH; Leister CA; Martin PT; Furlan PM; Mangano R
J Clin Psychopharmacol; 2000 Jun; 20(3):328-37. PubMed ID: 10831020
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the pharmacological profiles of the hypnotic drugs, zaleplon and zolpidem.
Sanger DJ; Morel E; Perrault G
Eur J Pharmacol; 1996 Oct; 313(1-2):35-42. PubMed ID: 8905326
[TBL] [Abstract][Full Text] [Related]
16. Different types of GABA(A) receptors may mediate the anticonflict and response rate-decreasing effects of zaleplon, zolpidem, and midazolam in squirrel monkeys.
Paronis CA; Cox ED; Cook JM; Bergman J
Psychopharmacology (Berl); 2001 Aug; 156(4):461-8. PubMed ID: 11498724
[TBL] [Abstract][Full Text] [Related]
17. Discriminative stimulus effects of benzodiazepine (BZ)(1) receptor-selective ligands in rhesus monkeys.
McMahon LR; Gerak LR; Carter L; Ma C; Cook JM; France CP
J Pharmacol Exp Ther; 2002 Feb; 300(2):505-12. PubMed ID: 11805210
[TBL] [Abstract][Full Text] [Related]
18. Cognition-impairing effects of benzodiazepine-type drugs: role of GABAA receptor subtypes in an executive function task in rhesus monkeys.
Makaron L; Moran CA; Namjoshi O; Rallapalli S; Cook JM; Rowlett JK
Pharmacol Biochem Behav; 2013 Mar; 104():62-8. PubMed ID: 23290931
[TBL] [Abstract][Full Text] [Related]
19. The Z-Drugs Zolpidem, Zaleplon, and Eszopiclone Have Varying Actions on Human GABA
Richter G; Liao VWY; Ahring PK; Chebib M
Front Neurosci; 2020; 14():599812. PubMed ID: 33328871
[TBL] [Abstract][Full Text] [Related]
20. Changes in GABA(A) receptor gene expression induced by withdrawal of, but not by long-term exposure to, zaleplon or zolpidem.
Follesa P; Mancuso L; Biggio F; Cagetti E; Franco M; Trapani G; Biggio G
Neuropharmacology; 2002 Feb; 42(2):191-8. PubMed ID: 11804615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
